Norman E. Taylor
No Rating Available
(Learn About Our Rating System)

Norman E. Taylor, MD, PhD

Languages spoken: English, Lao

  • Specialties

    • Anesthesiology

    Board Certification

    American Board of Anesthesiology
    National Board of Medical Examiners

  • Board Certification and Academic Information

    Academic Departments Anesthesiology -Primary
    Board Certification
    American Board of Anesthesiology
    National Board of Medical Examiners

    Education history

    Residency Anesthesia - Massachusetts General Hospital Resident
    Internship Aurora St. Luke’s Medical Center Transitional Internship
    Doctoral Training Physiology - Medical College of Wisconsin Ph.D.
    Professional Medical Medicine - Medical College of Wisconsin M.D.
    Undergraduate Chemical Engineering - Brigham Young University B.S.

    Selected Publications

    Journal Article

    1. Tadler SC, Jones KG, Lybbert C, Huang JC, Jawish R, Solzbacher D, Kendrick EJ, Pierson MD, Weischedel K, Rana N, Jacobs R, Vonesh LC, Feldman DA, Larson C, Hoffman N, Jessop JE, Larson AL, Taylor NE, Odell DH, Kuck K, Mickey BJ (2023). Propofol for treatment resistant depression: A randomized controlled trial. (Read full article)
    2. Ferrari LF, Wilkinson A, Cahoon C, Ramirez A, Rey C, Donaldson GW, Taylor NE (2023). Descending Control of Nociception (DCN) poorly predicts the development of persistent postsurgical pain-like behavior in consomic Dahl S rat strains. Anesthesiology, 139(4), 476-491. (Read full article)
    3. Taylor NE, Ferrari L (2023). Discovering chronic pain treatments: better animal models might help us get there. J Clin Invest, 133(5). (Read full article)
    4. Ferrari LF, Rey C, Ramirez A, Dziuba A, Zickella J, Zickella M, Raff H, Taylor NE (2022). Characterization of the Dahl salt-sensitive rat as a rodent model of inherited, widespread, persistent pain. Sci Rep, 12(1), 19348. (Read full article)
    5. Phero A, Ferrari LF, Taylor NE (2021). A novel rat model of temporomandibular disorder with improved face and construct validities. Life Sci, 286, 120023. (Read full article)
    6. Ferrari LF, Pei J, Zickella M, Rey C, Zickella J, Ramirez A, Taylor NE (2021). D2 Receptors in the Periaqueductal Gray/Dorsal Raphe Modulate Peripheral Inflammatory Hyperalgesia via the Rostral Ventral Medulla. Neuroscience, 463, 159-173. (Read full article)
    7. Vlasov K, Pei J, Nehs CJ, Guidera JA, Zhang ER, Kenny JD, Houle TT, Brenner GJ, Taylor NE, Solt K (2022). Activation of GABAergic Neurons in the Rostromedial Tegmental Nucleus and Other Brainstem Regions Promotes Sedation and Facilitates Sevoflurane Anesthesia in Mice. Anesth Analg, 132(4), e50-e55. (Read full article)
    8. Taylor NE, Long H, Pei J, Kukutla P, Phero A, Hadaegh F, Abdelnabi A, Solt K, Brenner GJ (2019). The rostromedial tegmental nucleus: a key modulator of pain and opioid analgesia. Pain, 160(11), 2524-2534. (Read full article)
    9. Taylor NE, Pei J, Zhang J, Vlasov KY, Davis T, Taylor E, Weng FJ, Van Dort CJ, Solt K, Brown EN (2019). The Role of Glutamatergic and Dopaminergic Neurons in the Periaqueductal Gray/Dorsal Raphe: Separating Analgesia and Anxiety. eNeuro, 6(1). (Read full article)
    10. Ionescu DF, Bentley KH, Eikermann M, Taylor N, Akeju O, Swee MB, Pavone KJ, Petrie SR, Dording C, Mischoulon D, Alpert JE, Brown EN, Baer L, Nock MK, Fava M, Cusin C (2018). Repeat-dose ketamine augmentation for treatment-resistant depression with chronic suicidal ideation: A randomized, double blind, placebo controlled trial. J Affect Disord, 243, 516-524. (Read full article)
    11. Albrecht DS, Forsberg A, Sandstrm A, Bergan C, Kadetoff D, Protsenko E, Lampa J, Lee YC, Hglund CO, Catana C, Cervenka S, Akeju O, Lekander M, Cohen G, Halldin C, Taylor N, Kim M, Hooker JM, Edwards RR, Napadow V, Kosek E, Loggia ML (2018). Brain glial activation in fibromyalgia - A multi-site positron emission tomography investigation. Brain Behav Immun, 75, 72-83. (Read full article)
    12. Zhang H, Zhao H, Zeng C, Van Dort C, Faingold CL, Taylor NE, Solt K, Feng HJ (2018). Optogenetic activation of 5-HT neurons in the dorsal raphe suppresses seizure-induced respiratory arrest and produces anticonvulsant effect in the DBA/1 mouse SUDEP model. Neurobiol Dis, 110, 47-58. (Read full article)
    13. Cusin C, Ionescu DF, Pavone KJ, Akeju O, Cassano P, Taylor NE, Eikermann M, Durham K, Swee MB, Chang T, Dording C, Soskin D, Kelley J, Mischoulon D, Brown EN, Fava M (2017). Ketamine augmentation for outpatients with treatment-resistant depression: Preliminary evidence for two-step intravenous dose escalation. Aust N Z J Psychiatry, 51(1), 55-64.
    14. Taylor NE, Van Dort CJ, Kenny JD, Pei J, Guidera JA, Vlasov KY, Lee JT, Boyden ES, Brown EN, Solt K (2016). Optogenetic activation of dopamine neurons in the ventral tegmental area induces reanimation from general anesthesia.LID - 201614340 [pii]. Proc Natl Acad Sci U S A. (Read full article)
    15. Ionescu DF, Swee MB, Pavone KJ, Taylor N, Akeju O, Baer L, Nyer M, Cassano P, Mischoulon D, Alpert JE, Brown EN, Nock MK, Fava M, Cusin C (2016). Rapid and Sustained Reductions in Current Suicidal Ideation Following Repeated Doses of Intravenous Ketamine: Secondary Analysis of an Open-Label Study. J Clin Psychiatry, 77(6), e719-25. (Read full article)

    Review

    1. Cowley AW Jr, Roman RJ, Mattson DL, Franchini KG, OConnor PM, Makino A, Taylor NE, Evans LC, Mori T, Dickhout JG, Jin C, Miyata N, Nakanishi K, Szentivnyi M Jr, Park F, Skelton MM, Kurth T, Shimada S (2024). Renal Medulla in Hypertension. [Review]. Hypertension. (Read full article)

  • Clinical Trials